Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19240089 | 0.95 | ALDH1A1 (0.48) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL14456204 | 0.93 | ALDH1A1 (0.49) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL20805921 | 0.87 | TSHR (0.45) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL12292368 | 0.83 | TSHR (0.41) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL19240031 | 0.83 | ALDH1A1 (0.64) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL12260843 | 0.80 | MAPT (0.42) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL9889261 | 0.80 | MAPT (0.42) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL12292355 | 0.80 | MAPT (0.42) | ALDH1A1GAATSHRMAPK1NPSR1 | |
| SCHEMBL13855938 | 0.80 | ALDH1A1 (0.51) | ALDH1A1GAATSHRMAPK1L3MBTL1 | |
| SCHEMBL19240018 | 0.77 | ALDH1A1 (0.67) | ALDH1A1GAAMAPK1NPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622603-B2 | Transesterifying a delta-aminopentadienoic acid ester that is alpha-substituted with an electron-withdrawing group (e.g., phenylsulfonyl) by reaction with an alcohol; tetraalkyl titanate catalyst | FUJIFILM CORPORATION (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20080076940-A1 | PROCESS FOR PRODUCING S-AMINOPENTADIENOATE COMPOUND | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076940-A1 | PROCESS FOR PRODUCING S-AMINOPENTADIENOATE COMPOUND | AASDHPPT, ADH1A, SSR4 | ALDH1A1 422/4885GAA 4708/4885TSHR 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.